Epizyme, Inc. (EPZM) Balance Sheet Annual

Epizyme, Inc.

EPZM (NASDAQ)

(%)

Financials
Epizyme, Inc. Balance Sheet Statement Annual

Annual Quarterly

* (except for per share items) of USD

Period Ending:	2021 12-31	2020 12-31	2019 12-31	2018 12-31	2017 12-31	2016 12-31	2015 12-31	2014 12-31	2013 12-31	2012 12-31	2011 12-31
Report Filing:	2022-03-01	2021-02-23	2020-02-27	2019-02-26	2018-03-13	2017-03-13	2016-03-09	2015-03-12	2014-02-28	2012-12-31	2011-12-31
Total Current Assets	206	405.1	399.2	272.5	285.8	248.7	213.1	195	159.7	100.6	35.42
Cash and Short Term Investments	176.8	373.6	381.1	240.3	276.4	242.2	208.3	190.1	123.6	97.98	33.34
Cash & Equivalents	98.34	168.2	139.5	86.67	226.7	77.89	208.3	190.1	123.6	97.98	33.34
Short Term Investments	78.45	205.4	241.6	153.6	49.77	164.3	0	0	0	0	0
Receivables	6.64	3.47	3.51	20.75	0.631	0.318	0.262	2.08	33.67	1.83	1.87
Inventory	3.22	10.46	0	0	0	0	0	0	0	0	0
Other Current Assets	19.39	17.55	14.58	11.48	8.73	6.16	4.48	2.84	2.42	0.815	0.208
Total Assets	289	473.6	424.6	275.5	289.4	252.4	217.9	199.2	163	103.5	37.36
Total Non-Current Assets	82.96	68.48	25.41	2.97	3.56	3.77	4.84	4.19	3.34	2.89	1.94
Property, Plant and Equipment	21.6	19.46	23.43	2.06	2.53	3.12	4.09	3.62	2.16	2.14	1.58
Goodwill and Intangible Assets	42.85	47	0	0	0	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0	0	0	0	0	0
Intangible Assets	42.85	47	0	0	0	0	0	0	0	0	0
Long Term Investments	0	0	0	0	0	0	0	0	0	0	0
Deferred Tax Assets	0	0	0	0	0	0	0	0	0	0	0.03
Other Long Term Assets	18.51	2.02	1.99	0.909	1.03	0.645	0.751	0.573	1.18	0.746	0.331
Total Current Liabilities	45.2	43.4	34.39	37.83	24.66	21.62	18.45	17.05	34.57	35.5	11.35
Accounts Payable	10.27	10.16	8.78	4.78	7	4.99	4.65	8.3	4.7	2.97	2.5
Notes Payable/Short Term Debt	4.15	4.67	3.04	0.016	0.11	0.62	0.561	0	0	0	0
Tax Payables	0	0	0	0	0	0	0	0	0	0	0
Deferred Revenue	11.95	0	3.81	13.3	28.81	28.81	1.9	1.7	23.24	28.21	7.1
Other Current Liabilities	18.83	28.57	18.76	19.74	-11.26	-12.8	11.34	7.04	6.63	4.33	1.75
Total Liabilities	309.7	288.7	93.45	42.49	53.99	50.74	48.37	38.92	58.67	154.6	88
Total Non-Current Liabilities	264.5	245.3	59.07	4.66	29.32	29.12	29.92	21.88	24.1	119.1	76.66
Total Long Term Debt	235	231.1	42.43	0.053	0	0.11	0.73	0	0	0	0
Deferred Tax Liabilities Non-Current	0	0	0	-0.053	0	-0.11	-0.73	0	0	0	0
Deferred Revenue Non-Current	11.95	0	3.81	3.81	28.81	28.81	28.81	21.45	23.63	41.24	22.72
Capital Lease Obligations	0	0	0	0	0	0	0	0	0	0	0
Other Long Term Liabilities	17.58	14.2	12.83	0.853	0.515	0.311	1.11	0.427	0.473	77.9	53.94
Total Equity	-20.69	184.9	331.1	233	235.4	201.7	169.5	160.3	104.3	-51.13	-50.64
Non-Controlling Interest	0	0	0	0	0	0	0	0	0	0	0
Total Stockholders' Equity	-20.69	184.9	331.1	233	235.4	201.7	169.5	160.3	104.3	-51.13	-50.64
Retained Earnings	-1,240	-988.7	-757	-586.7	-488.1	-353.7	-243.5	-111.1	-56.08	-52.6	-51.9
Accumulated Other Earnings	0.003	0.003	0.019	-0.054	-0.049	-0.106	-4.7	-3.28	-2.55	-1.84	-1.07
Common Stock	0.011	0.01	0.01	0.008	0.007	0.006	0.004	0.003	0.003	0	0
Preferred Stock	36.13	36.13	37.43	0	0	0	0	0	0	0	0
Additional Paid in Capital	1,183	1,137	1,051	819.8	723.5	555.5	417.7	274.6	162.9	3.31	2.32
Total Liabilities & Total Equity	289	473.6	424.6	275.5	289.4	252.4	217.9	199.2	163	103.5	37.36
Total Liabilities & Shareholders' Equity	289	473.6	424.6	275.5	289.4	252.4	217.9	199.2	163	103.5	37.36
Total Investments	78.45	205.4	241.6	153.6	49.77	164.3	0	0	0	0	0
Total Debt	239.1	235.7	45.47	0.069	0.11	0.73	1.29	0	0	0	0
Net Debt	140.8	67.53	-94.01	-86.6	-226.6	-77.17	-207	-190.1	-123.6	-97.98	-33.34

Market is Open

After-Hours Quote

Market is Open

After-Hours Quote

Epizyme, Inc. Balance Sheet Statement Annual